Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
Nonselective beta-blockers do not increase mortality in cirrhosis
New data published in Hepatology showed that nonselective beta-blockers did not increase all-cause or cirrhosis-related mortality in patients with advanced cirrhosis and ascites.
Overweight adolescents at increased risk for liver disease in adulthood
Swedish male adolescents who were overweight had an increased risk for developing severe liver disease — such as cirrhosis — later in life, according to results of a population-based study.
Log in or Sign up for Free to view tailored content for your specialty!
Stents control acute bleeding better vs. balloon tamponade in cirrhosis
Esophageal metal stents were more effective in controlling acute bleeding from varices in patients with cirrhosis and esophageal variceal bleeding and other adverse events vs. balloon tamponade, according to results of a controlled trial.
VIDEO: Prevalence of NASH-induced cirrhosis more than doubled between 1999 and 2012
SAN DIEGO — In this exclusive video from DDW 2016, Naim Alkhouri, MD, a hepatologist from the Cleveland Clinic, discusses the increasing prevalence and burden of nonalcoholic steatohepatitis-induced cirrhosis in the U.S.
Cirrhosis incidence low in Sweden
Over the course of 10 years, cirrhosis incidence was lowest in Southern Sweden compared with all other European countries, according to results of a population-based study.
TIPS increases quality of life after 1 year vs. endoscopy and beta-blocker
SAN DIEGO — Patients with cirrhosis had improved quality of life one year after treatment with transjugular intrahepatic portosystemic shunt placement compared with endoscopic therapy plus beta-blocker, for the secondary prevention of gastroesophageal variceal bleeding, according to a study presented at DDW 2016.
Acute HEV rare in patients with acute liver failure
Acute hepatitis E virus infection was not prevalent in American patients with acute liver failure, according to published findings.
Terlipressin plus albumin improves renal function for cirrhosis, HRS-1
The combination of terlipressin and albumin was more effective in improving renal function in patients with cirrhosis and hepatorenal syndrome type I vs. albumin alone, according to data from a phase 3 clinical trial.
Duodenal microbiota may play a role in liver cirrhosis
SAN DIEGO — Variation in duodenal microbiota was more pronounced in individuals with liver cirrhosis than in healthy controls, suggesting that these microbiota may be involved in cirrhosis, according to a presenter at DDW 2016.
ELF, sCD163 scores accurately predict portal hypertension in cirrhosis
The Enhanced Liver Fibrosis score combined with soluble CD163 marker successfully predicted significant portal hypertension in patients with cirrhosis.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read